Mosaic ImmunoEngineering Inc. (CPMV) stock
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $2.41M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$687.35K
- EPS, diluted
- -$0.08
- Book value per share
- -$1.08
- Diluted shares
- 7M
Trading
- Previous close
- $0.33
- Open
- $0.33
- Day's range
- $0.33 – $0.33
- Volume
- 0
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | CPMV | S&P 500 | Difference | CPMV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +291.8% | +0.6% | +291.1 pts | ||
| 3 months | -47.9% | +3.4% | −51.2 pts | ||
| Year to date | +7.1% | +13.3% | −6.2 pts | ||
| 1 year | -68.3% | +16.6% | −84.9 pts | ||
| 3 years | -41.6% | +86.4% | −128.0 pts | -16.4% | +23.1% |
| 5 years | -72.2% | +81.9% | −154.1 pts | -22.6% | +12.7% |
| 10 years | -90.5% | +318.9% | −409.3 pts | -21.0% | +15.4% |
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Mosaic ImmunoEngineering filed with the SEC as exhibits to Form 8-K or 6-K
About Mosaic ImmunoEngineering
Biological Products, (No Diagnostic Substances)
Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company focused on advancing and commercializing immunotherapies for the treatment of cancer. The company works to identify, acquire, or license new product candidates and platforms to construct a product pipeline centered around cancer immunotherapy treatments. It has previously engaged in advisory and related services for external study projects. The company does not currently maintain an active development pipeline and seeks to serve medical patients through potential future therapeutic solutions.
Company profile, executives and historyMosaic ImmunoEngineering stock: common questions
What is Mosaic ImmunoEngineering's stock price?
CPMV closed at $0.33 on Oct 19, 2026, up 0.00% on the day.
What is Mosaic ImmunoEngineering's market cap?
Mosaic ImmunoEngineering was worth $2.41M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is CPMV's P/E ratio?
Mosaic ImmunoEngineering lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.08), so it has no meaningful P/E ratio.
Does Mosaic ImmunoEngineering pay a dividend?
No. Mosaic ImmunoEngineering has not paid a cash dividend over the last twelve months.
How has CPMV stock performed over the past year?
Including dividends, CPMV returned -68.3% over the past year, against +16.6% for the S&P 500.
Who are Mosaic ImmunoEngineering's competitors?
Companies most similar to Mosaic ImmunoEngineering by business, industry and size include CERO, TIL, CLDI, INAB, LIMN.
See a number that looks wrong?